IO Biotech, Inc. (IOBTQ) Current Leases (2022 - 2025)
IO Biotech's (IOBTQ) quarterly Current Leases came in at $788000.0 in Q3 2025, up 12.57% YoY from $700000.0 in Q3 2024, and down 1.5% on a QoQ basis from $800000.0 in Q2 2025.
IO Biotech, Inc. (IOBTQ) Current Leases (2022 - 2025) Analysis & Trends
IO Biotech (IOBTQ) has 4 years of Current Leases data on file, last reported at $788000.0 in Q3 2025.
- Quarterly Current Leases rose 12.57% year-over-year to $788000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $788000.0 (up 12.57% YoY) and the FY2024 annual result came in at $717000.0, up 9.47% from the prior year.
- Current Leases fell to $788000.0 in Q3 2025, from $800000.0 in the prior quarter.
- In the past five years, Current Leases ranged from a high of $800000.0 in Q2 2025 to a low of $345000.0 in Q1 2022.
- A 4-year average of $623466.7 and a median of $655000.0 in 2023 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases surged 62.03% — and 2025, when it climbed 5.0%.
- Tracing IOBTQ's Current Leases over 4 years: stood at $515000.0 in 2022, then increased by 27.18% to $655000.0 in 2023, then grew by 9.47% to $717000.0 in 2024, then grew by 9.9% to $788000.0 in 2025.
- The last three Current Leases figures came in at $788000.0 (Q3 2025), $800000.0 (Q2 2025), and $735000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 788,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 735,000.00 |
| Dec 31, 2024 | 717,000.00 |
| Sep 30, 2024 | 700,000.00 |
| Jun 30, 2024 | 700,000.00 |
| Mar 31, 2024 | 700,000.00 |
| Dec 31, 2023 | 655,000.00 |
| Sep 30, 2023 | 627,000.00 |
| Jun 30, 2023 | 600,000.00 |
| Mar 31, 2023 | 559,000.00 |
| Dec 31, 2022 | 515,000.00 |
| Sep 30, 2022 | 492,000.00 |
| Jun 30, 2022 | 419,000.00 |
| Mar 31, 2022 | 345,000.00 |